Recent updates

Browse recent updates. BMJ Best Practice is continuously updated to provide the latest evidence-based decision support.

  • 13 May 2025​US FDA approves gepotidacin, a first-in-class antibiotic for UTIs in womenTopic:Urinary tract infections in women
  • 25 Apr 2025WHO reaffirms mpox outbreak in Africa still meets criteria for a public health emergency of international concernTopic:Mpox
  • 24 Apr 2025Dapagliflozin approved by FDA for treatment of type 2 diabetes in childrenTopic:Type 2 diabetes in children
  • 19 Mar 2025Esketamine approved in the US as the first ever monotherapy for treatment-resistant depression in adultsTopic:Depression in adults
  • 14 Mar 2025Guidelines recommend statins for people living with HIV to prevent cardiovascular eventsTopic:HIV in adults
  • 05 Mar 2025FDA approves olezarsen for the treatment of familial chylomicronemia syndromeTopic:Hypertriglyceridemia
  • 11 Feb 2025First bird flu death reported in the US outbreak; case of human infection detected in the UKTopic:Avian influenza A (H5N1) virus infection
  • 17 Jan 2025WHO recommends first single-dose drug for Plasmodium vivax malariaTopic:Malaria
  • 06 Dec 2024Epinephrine (adrenaline): new intranasal formulation treatment approved for management of anaphylaxisTopic:Anaphylaxis
  • 04 Dec 2024FDA grants approval of seladelpar, expanding options for second-line treatmentTopic:Primary biliary cholangitis
  • 19 Nov 2024 pneumonia in people with HIV whose CD4 count is between 100 and 200 cells/mm³​Topic:Pneumocystis jirovecii pneumonia
  • 19 Nov 2024WHO recommends fexinidazole for rhodesiense HATTopic:African trypanosomiasis
  • 15 Nov 2024FDA approves palopegteriparatide for hypoparathyroidism in adultsTopic:Hypoparathyroidism
  • 15 Nov 2024Clinicians urged to consider parvovirus B19 in people with fever, myalgia, arthralgia, and rash, after US and Europe report increased casesTopic:Erythema infectiosum
  • 13 Nov 2024US FDA approves new treatment for schizophrenia, the first drug with a novel target in decadesTopic:Schizophrenia
  • 13 Nov 2024US FDA approves new treatment for schizophrenia, the first drug with a novel target in decadesTopic:Schizophrenia
  • 06 Aug 2024Updated American College of Gastroenterology guidance includes new fluid resuscitation recommendations for patients with acute pancreatitisTopic:Acute pancreatitis